| 注册
首页|期刊导航|中国药物评价|中成药临床综合评价的现状、挑战与展望

中成药临床综合评价的现状、挑战与展望

王丽梅 李璠 阳剑 杨鹃溶 周思言

中国药物评价2025,Vol.42Issue(1):1-5,5.
中国药物评价2025,Vol.42Issue(1):1-5,5.

中成药临床综合评价的现状、挑战与展望

The Current Situation,Challenges and Prospects of Comprehensive Evaluation of Traditional Chinese Medicine in Clinical Practice

王丽梅 1李璠 2阳剑 1杨鹃溶 1周思言1

作者信息

  • 1. 云南省药物政策研究中心,云南 昆明 650500||昆明医科大学药学院暨云南省天然药物药理重点实验室,云南 昆明 650500
  • 2. 云南省药物政策研究中心,云南 昆明 650500||昆明医科大学科技成果孵化中心,云南 昆明 650500
  • 折叠

摘要

Abstract

Clinical comprehensive evaluation of proprietary Chinese medicine is an important driving force to promote the development of academic theory and clinical practice of traditional Chinese medicine.This paper reviewed the development status of clinical compre-hensive evaluation of proprietary Chinese medicines.At present,the evaluation standards and procedures are not unified,the evaluation content is not comprehensive,and The quality of the original research data is generally low.How to reflect the characteristics of traditional Chinese medicine is a major difficulty,and relevant suggestions were put forward to address the above problems,in order to provide refer-ence for the comprehensive evaluation and development of proprietary Chinese medicines.

关键词

中成药临床综合评价/指标体系/证据质量/中医药特色

Key words

Clinical comprehensive evaluation of proprietary Chinese medicine/Indicator system/Quality of evidence/Characteris-tics of Chinese medicine

分类

药学

引用本文复制引用

王丽梅,李璠,阳剑,杨鹃溶,周思言..中成药临床综合评价的现状、挑战与展望[J].中国药物评价,2025,42(1):1-5,5.

中国药物评价

2095-3593

访问量1
|
下载量0
段落导航相关论文